NRX Pharmaceuticals Inc (NRXP) — Financial Flexibility Index
NRX Pharmaceuticals Inc (NRXP) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of $-2.89 Million (operating CF $-2.89 Million minus capex $0.00) represents 0% of total liabilities ($40.75 Million). Also explore NRXP year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NRX Pharmaceuticals Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NRX Pharmaceuticals Inc across 8 annual periods. Check asset resilience ratio of NRX Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for NRX Pharmaceuticals Inc (2017–2024)
Year-by-year free cash flow to debt coverage for NRX Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of NRX Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.40x | $-10.64 Million | $-10.64 Million | $26.87 Million | ▲ +65.2% |
| 2023 | -1.14x | $-21.65 Million | $-21.66 Million | $19.05 Million | ▲ +47.4% |
| 2022 | -2.16x | $-39.74 Million | $-39.76 Million | $18.41 Million | ▲ +31.7% |
| 2021 | -3.16x | $-37.70 Million | $-37.70 Million | $11.92 Million | ▼ -6426.1% |
| 2020 | -0.05x | $-2.26 Million | $-2.27 Million | $46.71 Million | ▲ +84.3% |
| 2019 | -0.31x | $-792.73K | $-792.73K | $2.57 Million | ▲ +18.2% |
| 2018 | -0.38x | $-473.19K | $-473.19K | $1.26 Million | ▲ +74.2% |
| 2017 | -1.46x | $-135.81K | $-135.81K | $93.17K | — |